🇩🇪 Germany Country × Condition
obesity Clinical Trials in Germany
Active clinical trials for obesity with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇩🇪 Germany
Active Trials in Germany (5)
NCT03934957
Recruiting
Hamburg City Health Study - a German Cohort Study
Enrollment
45,000 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT07754474 Phase 1
Recruiting
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity
Enrollment
70 pts
Country
🇩🇪 Germany
Boehringer Ingelheim
View Trial → NCT06396871
Recruiting
Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
Enrollment
180 pts
Country
🇩🇪 Germany
Technische Universität Dresden
View Trial → NCT07557953 Phase 1
Recruiting
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
Enrollment
120 pts
Country
🇩🇪 Germany
Novo Nordisk A/S
View Trial → NCT03072537
Recruiting
CrescNet - Growth Monitoring Network
Enrollment
1,000,000 pts
Country
🇩🇪 Germany
University of Leipzig
View Trial → Frequently Asked Questions
How many obesity clinical trials are active in Germany?
There are currently 5 active clinical trials for obesity with sites in Germany, of which 5 are actively recruiting patients.
How can I join a obesity clinical trial in Germany?
To join a obesity clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Germany?
Active obesity trials in Germany span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology